Li M, Gao N, Wang SL, Guo YF, Liu Z. Hotspots and trends of risk factors in gastric cancer: A visualization and bibliometric analysis. World J Gastrointest Oncol 2024; 16(5): 2200-2218 [PMID: 38764808 DOI: 10.4251/wjgo.v16.i5.2200]
Corresponding Author of This Article
Meng Li, PhD, Doctor, Department of Gastroenterology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, No. 5 Beixiange Street, Xicheng District, Beijing 100053, China. zyxyjslm@163.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Scientometrics
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Oncol. May 15, 2024; 16(5): 2200-2218 Published online May 15, 2024. doi: 10.4251/wjgo.v16.i5.2200
Table 1 The top 10 most productive countries in research
Rank
Country
TP
Percent (%)
TC
CPP
1
China
1061
42.20
22402
21.11
2
Japan
467
18.58
13585
29.09
3
United States
383
15.23
21194
55.34
4
South Korea
311
12.37
6831
21.96
5
Italy
152
6.05
7327
48.20
6
Sweden
122
4.85
5669
46.47
7
Germany
116
4.61
4919
42.41
8
United Kingdom
108
4.30
7949
73.60
9
Spain
89
3.54
4225
47.47
10
Netherlands
83
3.30
4757
57.31
Table 2 The top 10 most productive institutions in gastroparesis research
Rank
Institution
Country
TP
TC
CPP
1
National Cancer Center
Korea
138
5475
39.67
2
Nanjing Medical University
China
122
2906
23.82
3
National Cancer Institute
United States
104
9330
89.71
4
Seoul National University
Korea
88
2336
26.55
5
China Medical University
China
81
1460
18.02
6
Karolinska Institute
Sweden
73
3111
42.62
7
Fudan University
China
57
1435
25.18
8
Shanghai Jiao Tong University
China
57
1706
29.93
9
Yonsei University
Korea
53
1628
30.72
10
Vanderbilt University
United States
50
2843
56.86
Table 3 The top 10 Journals with the largest number of publications in research
Rank
Journal
TP
TC
CPP
JCR
IF2021
1
International Journal of Cancer
115
6620
57.57
Q2
4.37
2
Gastric Cancer
71
1751
24.66
Q1
7.70
3
Plos One
71
1417
19.96
Q2
3.75
4
World Journal of Gastroenterology
71
2364
33.30
Q2
5.37
5
Asian Pacific Journal of Cancer Prevention
56
742
13.25
-
-
6
Cancer Epidemiology Biomarkers & Prevention
55
3968
72.15
-
-
7
Annals of Surgical Oncology
42
1350
32.14
Q1
4.34
8
BMC Cancer
42
843
20.07
Q2
4.64
9
Oncotarget
41
849
20.71
-
-
10
Medicine
40
605
15.13
Q3
1.82
Table 4 The top 10 authors and co-cited authors in risk factors for gastric cancer research
Rank
Author
TP
TC
CPP
Co-cited author
Co-citations
1
Il Ju Choi
36
706
19.61
P Correa
617
2
Shoichiro Tsugane
34
1021
30.03
Dm Parkin
422
3
Jeongseon Kim
31
619
19.97
Ca Gonzalez
393
4
Yuan yuan
31
526
16.97
J Ferlay
352
5
Christian C Abnet
30
1161
38.70
Em El-omar
271
6
Wong-ho Chow
23
1091
47.43
F Bray
270
7
Ping Li
22
336
15.27
A Jemal
241
8
Xiao-ou Shu
22
564
25.64
N Uemura
233
9
Li Yang
22
414
18.82
M Rugge
230
10
Wei Zheng
22
564
25.64
P Lauren
228
Table 5 The top 10 documents in citation analysis of publications in risk factors for gastric cancer research
Rank
Title
First author
Source
Publication year
TC
1
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
Emad M El-Omar
Nature
2000
1800
2
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial
Benjamin Chun-Yu Wong
Jama
2004
1045
3
Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention
Parisa Karimi
Cancer Epidemiol Biomarkers Prev
2014
1015
4
Helicobacter pylori and gastric cancer: factors that modulate disease risk
Lydia E Wroblewski
Clin Microbiol Rev
2010
811
5
Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms
Emad M El-Omar
Gastroenterology
2003
711
6
Population attributable risks of esophageal and gastric cancers
Lawrence S Engel
J Natl Cancer Inst
2003
513
7
Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China
Gina D Tran
Int J Cancer
2005
494
8
Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands
Annemarie C de Vries
Gastroenterology
2008
468
9
Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer
Hiroshi Ohata
Int J Cancer
2004
376
10
Gastric cancer epidemiology and risk factors
Douglas E Guggenheim
J Surg Oncol
2013
346
Table 6 The top 10 documents in co-citation analysis of publications in risk factors for gastric cancer research
Rank
Title
First author
Source
Publication year
TC
1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray
Ca-cancer J Clin
2018
251
2
The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification.
P Lauren
Acta Pathol Mic Sc
1965
224
3
Helicobacter pylori infection and the development of gastric cancer
N Uemura
New Engl J Med
2001
207
4
Global cancer statistics, 2002
D Max Parkin
Ca-cancer J Clin
2005
196
5
Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994
M F Dixon
Am J Surg Pathol
1996
180
6
Bias in meta-analysis detected by a simple, graphical test
M Egger
BMJ
1997
159
7
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay
Int J Cancer
2015
150
8
Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts
Helicobacter and Cancer Collaborative Group
Gut
2001
144
9
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
M Egger
BMJ
1997
137
10
Meta-analysis in clinical trials
R DerSimonian
Control Clin Trials
1986
126
Table 7 The top 20 risk factors for gastric cancer
Rank
Keyword
TP
Rank
Keyword
TP
1
Helicobacter pylori infection
717
11
Nutrient intake
62
2
Polymorphism
326
12
DNA methylation
40
3
Smoking
218
13
Life-style
36
4
Diet
137
14
Fruit
33
5
Alcohol
112
15
Pepsinogen
32
6
IM
99
16
Promoter polymorphism
31
7
Inflammation
98
17
Lymphadenectomy
29
8
Obesity
91
18
Necrosis-factor-alpha
29
9
Caga
63
19
s-1
29
10
Biomarker
62
20
p53
27
Table 8 Research characteristics of gastric cancer risk prediction models
Research characteristics
Model characteristics
Findings
Ref.
Country
Research design
Number of participants
Data types
Model types
AUC
C-index
China
Prospective cohort study
435673
①②③④
c
-
0.736
The GCRS can be an effective risk assessment tool for tailored endoscopic screening of GC in China. RESCUE, an online tool was developed to aid the use of GCRS
Li’s prediction model performs the best for risk stratification in the screening, detection, and diagnosis of GC and precancerous lesions, whereas the overall performance of the other three models is similar
This model could enable a potentially more cost- effective endoscopic surveillance program, as well as to exclude very low-risk patients from unnecessary surveillance
The present study established a predictive model to assess the risk of GC using high-evidence genetic variants and detected the potential gene-environment interaction, which may be helpful in prevention of the cancer
This model is simple, convenient, and economical, has good patient compliance, is easy to implement clinically, is easy to concentrate medical resources, and is expected to identify high-risk groups at an early stage, then to increase the detection rate of GC
The addition of ethnic and cultural variables, particularly the immigration/generation, to conventional risk factor variables improved the ability of models to identify individuals at high risk for GC
The prediction rule had good performance and showed significantly better discrimination ability to identify a patient with GC than three other alternative prediction methods
A serological biopsy composed of the five stomach-specific circulating biomarkers could be used to identify high-risk individuals for further diagnostic gastroscopy, and to stratify individuals’ risk of developing GC and thus to guide targeted screening and precision prevention
In this study, the authors developed a model and a simple scoring system to estimate an individual's risk of developing GC, based on factors such as H. pylori antibodies, serum pepsinogen levels, and lifestyle habits
This study provides the first predictive model for assessing the risk factors for GC in Korea, where the incidence rate of GC is high. This study has also identified new risk factors for GC, such as drinking tap water
Citation: Li M, Gao N, Wang SL, Guo YF, Liu Z. Hotspots and trends of risk factors in gastric cancer: A visualization and bibliometric analysis. World J Gastrointest Oncol 2024; 16(5): 2200-2218